Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 264

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 264
---
 assure that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Redemptions of Public Shares On December 20, 2022, stockholders holding 26,186,896 Public Shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $ 10.08 per share, for an aggregate redemption

<div align='center'>F-58</div>

amount of $ 263,963,913 . Following such redemptions, 1,413,104 Public Shares remained outstanding in the trust. During 2023, the redemption price was adjusted which resulted in the net payment of $ 298,431 of the second tranche redemption payment. On September 7, 2023, stockholders holding 1,006,495 Public Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $ 10.29 per share, subject to adjustment for applicable taxes, including, but not limited to, franchise tax, excise tax and income tax, for an aggregate redemption amount of $ 10,358,754 . Following such redemptions, 406,609 Public Shares remained outstanding. In January 2024, the Company recovered an excess redemption to shareholders in the amount of $ 294,669 for federal tax payments that were due. On March 7, 2024, stockholders holding 119,572 Public Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $ 10.58 per share, adjusted for applicable taxes in the amount of $ 60,000 , including, but not limited to, franchise tax, excise tax and income tax, for an aggregate redemption amount of $ 1,265,669 . Following such redemptions, 287,037 Public Shares remained outstanding. The redemptions were settled on April 2, 2024. On September 5, 2024, stockholders holding 48,107 Public Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $ 11.17 per share, subject to adjustment for applicable taxes, including, but not limited to, franchise tax, excise tax and income tax, for an aggregate redemption amount of $ 537,200 . Following such redemptions, 238,930 Public Shares